Share this article and save a life!
Healthcare AI just raised $2 billion in 3 weeks. Are we ready?
The numbers are staggering:
• Angle Health: $134 million for AI-powered benefits modernization
• Paradigm Health: $78 million for clinical research AI automation
• Artera: $65 million for autonomous care support systems
• Abridge: $300 million for ambient AI documentation
• Ambience Healthcare: $243 million for clinical AI scribes
• Commure: $200 million for ambient AI platforms
That’s just December 2025. Not the whole year. Just three weeks.
💡 Here’s what’s really happening:
Startups are capturing 85% of generative AI healthcare spending while established health systems scramble to keep up. Mayo Clinic announced a $1 billion AI investment. Advocate Health is deploying dozens of AI projects simultaneously.
The FDA just qualified its first AI tool for drug development on December 9th, specifically for MASH clinical trials. This isn’t just diagnostic support anymore, it’s AI directly integrated into the pharmaceutical pipeline.
JP Morgan reports that AI-focused deals now comprise 75% of all health tech funding in 2025. Think about that. Three quarters of every healthcare investment dollar is betting on artificial intelligence.
But here’s my concern:
We’re pouring billions into AI solutions while basic healthcare infrastructure crumbles. Rural hospitals close. FQHCs face funding cliffs. Primary care deserts expand.
Are we building AI castles on quicksand?
The technology is revolutionary. The potential is undeniable. But without addressing fundamental healthcare access and infrastructure, we risk creating a two-tier system: AI-enhanced care for the privileged, and nothing for everyone else.
The real question isn’t whether AI will transform healthcare.
It’s whether we’ll use it to heal our broken system or deepen its divides.
♻️ Repost if healthcare AI needs infrastructure investment first
👉 Follow me, Jonathan Govette, for real-time updates on healthcare technology and business news. LinkedIn Profile: https://www.linkedin.com/in/jonathangovette/
Share this article and save a life!
Author:
CEO/Co-Founder @ Oatmeal Health | AI Lung Cancer Screening | Almost Became a Doctor | Engineer | Follow to Share What I’ve Learned Along the Way
I help patients get the care they need earlier, preventing late-stage cancer.
That’s been the throughline across three companies and almost 20 years in healthcare. At ReferralMD, we fixed broken referral networks so patients didn’t fall through the cracks. At Oatmeal Health, it’s lung cancer: building the diagnostic and screening infrastructure so the 85% of cases caught too late get caught early instead.
Today as CEO of Oatmeal Health, I lead a team embedding AI into radiology workflows to turn routine lung CT scans into reimbursable cancer risk assessments. We partner with FQHCs to reach underserved communities, and with health systems and payers to make early detection economically sustainable. Think HeartFlow or Cleerly, but for lungs.
Between companies, I advised at Techstars and Plug and Play, mentoring founders building in digital health. That experience shaped how I think about what separates companies that ship from companies that stall: distribution, reimbursement, and clinical trust, not just technology.
I’m a CancerX alumnus, a 3x healthcare founder, and someone who believes the biggest problems in cancer aren’t scientific. They’re operational.
We’re hiring mission-driven builders at Oatmeal Health. If you want to work on something that matters, reach out.
When I’m not working, I’m traveling, mentoring, and keeping up with one very energetic husky. 🐾
Substack – The Oatmeal Bite:
Millions of patients get less care because of who they are, where they live, or how they look. I’m fighting to change that. CEO @OatmealHealth, a startup built for the underserved. The Oatmeal Bite: intel for clinicians, investors, and advocates.
Jonathan Govette
CEO of Oatmeal Health
Substack:
https://oatmealhealthjonathangovette.substack.com/
